Convergent synthesis of Bryostatins
Convergent synthesis of Bryostatins
批准号:
EP/F049838/1
负责人:
Eric Thomas
金额:
$12.63万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2008
资助国家:
英国
项目状态:
已结题
起止时间:
2008 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Compounds isolated from natural sources, for example plants, have provided very important leads over the years for the discovery of drugs and pharmaceuticals. Recently, many very complicated compounds have been isolated from microorganisms in the sea and found to possess anti-cancer activity. One such group of compounds are the bryostatins. These display potent biological activity and are being tested for clinical use in many trials worldwide. The problem is that access to the bryostatins is very difficult. Aquaculture techniques are providing a few hundred grammes a year of one of the bryostatins, but this supply is not meeting demand and, in particular, is not providing enough material for the chemical modifications necessary for a study of the influence of structure on biological activity. To date, three syntheses of bryostatins have been reported, two from the USA and one from Japan. These are outstanding examples of modern and sophisticated chemical synthesis but because of their length cannot contribute significantly to the supply of bryostatins or analogues for biological studies.It is intended to develop a shorter synthesis of bryostatins which will provide access to synthetic analogues for studies of the effect of structure on biological activity. Initially a naturally occurring bryostatin will be prepared to develop the methodology but this should open the way for the preparation of analogues. The longer term objective, albeit outside the scope of this application, is to prepare a simpler analogue with improved biological activity and reduced toxicityHowever, this is a very ambitious programme and synthetic organic chemistry at this level is very difficult to carry out. The present application is for support for an experienced research worker to continue our studies in this area for twelve months. During this time it is intended to finalise our synthetic strategy, to prepare close analogues of the bryostatins, and hopefully prepare a natural bryostatin, so establishing the viability of our approach.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1039/c8ob03152e
发表时间:
2019-02
期刊:
Organic & biomolecular chemistry
影响因子:
3.2
作者:
[Paul R. Mears;S. Hoekman;Claire E. Rye;F. P. Bailey;D. Byrne;P. Eyers;E. Thomas]
通讯作者:
Paul R. Mears;S. Hoekman;Claire E. Rye;F. P. Bailey;D. Byrne;P. Eyers;E. Thomas
Total syntheses of vioprolides for further biological evaluation
-
批准号:EP/L012898/1
-
项目类别:Research Grant
-
资助金额:$48.32万
-
财政年份:2014
-
负责人:Eric Thomas
-
依托单位:
Convergent syntheses of bryostatins
-
批准号:EP/H03255X/1
-
项目类别:Research Grant
-
资助金额:$26.63万
-
财政年份:2010
-
负责人:Eric Thomas
-
依托单位:
Dynamic modulators: Novel effectors of NF-kappaB signalling
-
批准号:BB/E01366X/1
-
项目类别:Research Grant
-
资助金额:$71.31万
-
财政年份:2007
-
负责人:Eric Thomas
-
依托单位:
国内基金
海外基金
登录
查看更多内容
胆固醇合成蛋白CYP51介导线粒体通透性转换诱发Th17/Treg细胞稳态失衡在舍格伦综合征中的作用机制研究
-
批准号:82370976
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:郑凌艳
-
依托单位:
“肠—肝轴”PPARα/CYP8B1胆汁酸合成信号通路在减重手术改善糖脂代谢中的作用与机制
-
批准号:82370902
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:田景琰
-
依托单位:
lncGEI诱导湖羊卵巢颗粒细胞E2合成的分子机制
-
批准号:32372856
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2023
-
负责人:李隐侠
-
依托单位:
脂肪酸合成通过GDF15/IRS2介导胰岛素抵抗促进血管内皮细胞活化导致脓毒症肺损伤的机制研究
-
批准号:82372203
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:李然然
-
依托单位:
环状RNA circ-PRKAA1调控肝癌细胞脂代谢重编程的研究
-
批准号:32000527
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:李启东
-
依托单位:
ALDH6A1缺损重塑糖脂代谢促进肝细胞癌发生的机制研究
-
批准号:91957109
-
项目类别:重大研究计划
-
资助金额:79.0万元
-
批准年份:2019
-
负责人:黄赞
-
依托单位:
新型滤波器综合技术-直接综合技术(Direct synthesis Technique)的研究及应用
-
批准号:61671111
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:肖飞
-
依托单位:
双硅化合物反应及天然产物合成应用研究
-
批准号:21172150
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:宋振雷
-
依托单位:
新型M4受体选择性拮抗剂的研究
-
批准号:30973615
-
项目类别:面上项目
-
资助金额:32.0万元
-
批准年份:2009
-
负责人:何新华
-
依托单位:
基于penicillide结构的类天然产物合成及其胆固醇酯转运蛋白抑制的研究
-
批准号:20872019
-
项目类别:面上项目
-
资助金额:32.0万元
-
批准年份:2008
-
负责人:雷新胜
-
依托单位: